South American Blastomycosis Clinical Presentation

  • Author: Julie E Dixon, MD, FAAD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Jan 24, 2012
 

History

After the inhalation of conidia, the fungus transforms into yeastlike cells inside the alveolar macrophages. This transformation induces a nonspecific inflammatory response, which generally limits the disease at this point. Most patients have no signs or symptoms.

  • Adult chronic
    • After a latency period of weeks to decades, some adults have a chronic progressive form of the disease. The skin, mucous membranes, lungs, and lymph nodes primarily are affected.
    • Constitutional symptoms include low-grade fever, malaise, and weight loss.
    • Mucous membrane symptoms include pain at ulceration sites. Oral lesions may lead to pain with eating or drinking. Laryngeal and pharyngeal lesions can cause dysphagia, hoarseness, or stridor.
    • Respiratory symptoms include cough; mucous production, which may be blood-tinged; and dyspnea. Symptoms due to involvement of other organ systems are sometimes seen, such as abdominal pain from gastrointestinal involvement or headache from central nervous system involvement.
  • Juvenile subacute
    • After a brief latency period, some children have a subacute severe disseminated form of the disease. In children, the major target of South American blastomycosis is the reticuloendothelial system.
    • Symptoms include fever, asthenia, anorexia, malaise, weight loss, and diarrhea.
    • Mucous membrane and respiratory symptoms are unusual.
    • Most other symptoms are related to lymph node enlargement, suppuration, and sinus tract formation.
Next

Physical

  • Adult chronic
    • Mucous membranes[10] : Approximately one half of patients with chronic disseminated disease seek medical attention because of mucocutaneous lesions. Oral, nasal, pharyngeal, and laryngeal lesions begin as papules or plaques, which ulcerate. The lesions typically have granulomatous, mulberrylike surfaces and most commonly occur on the lips, gingiva, palate, buccal mucosa, and tongue. Lesions progress over months and are painful. Gingival lesions cause the loss of teeth, which makes eating difficult. Lesions slowly enlarge and coalesce, increasing the difficulties. Conjunctivitis and ulcerative lesions of the perianal area occasionally occur. See the image below. Ulcerated nodule on the tongue in a man with SouthUlcerated nodule on the tongue in a man with South American blastomycosis. Courtesy of Heidi Logemann, Professor of Mycology, Universidad de San Carlos, Guatemala.
    • Skin: Skin lesions, which occur most commonly on the face, are polymorphous. They may be papular, nodular, ulcerated, papillomatous, or even tuberous. They most often arise from the direct extension of mucous membrane lesions. Occasionally, hematogenous spread results in widely scattered lesions and subcutaneous abscesses. Lymph node breakdown can lead to cutaneous fistulae. Without treatment, lesions gradually enlarge. See the image below. Crusted plaques over the central part of the face Crusted plaques over the central part of the face in a man with South American blastomycosis. Courtesy of Rolando Vasquez, MD, Professor of Dermatology, Guatemala.
    • Lymph nodes: Extensive lymphadenopathy develops. Numerous visceral and subcutaneous nodes may be involved through hematogenous and lymphatic spread. Cervical nodes are commonly affected. Nodes are hypertrophic, firm, and painful. They sometimes suppurate, forming sinus tracts or ulcers in the skin.
    • Respiratory: Lung involvement occurs in 70-80% of patients. In 25% of patients with the chronic adult type of disease, the lungs are the only organ system involved. The clinical picture often resembles that of tuberculosis. Chronic dyspnea, cough, and sputum production develop.
    • Other: Hepatosplenomegaly, caused by hepatic and splenic lesions, occurs in approximately 5% of cases. Central nervous system involvement, both meningitis and parenchymal granulomatous disease, is observed in 5-25% of patients and causes mental status changes and seizures.[11] Occasionally, adrenal insufficiency due to the destruction of the adrenal glands is observed. Intestinal ulcerations and osteomyelitis are other infrequent manifestations.
  • Juvenile subacute
    • Mucous membranes: Mucosal involvement is rare, but mucosal ulcerations occasionally occur.
    • Skin: Subacute disease may be associated with an acneiform eruption or subcutaneous abscesses. Sometimes, scrofuloderma is produced as a result of suppuration of the underlying lymph nodes.
    • Lymph nodes: Lymphadenopathy is prominent. Nodes may enlarge to such a point that infection with P brasiliensis may be confused with leukemia or lymphoma. Lymph nodes often suppurate and form sinus tracts to the skin. Mesenteric adenopathy may lead to bowel obstruction.
    • Respiratory: Pneumonia sometimes occurs.
    • Other: Cachexia, hepatosplenomegaly, adrenal insufficiency, osteomyelitis, and gastrointestinal problems may also occur.
Previous
Next

Causes

  • The disease is caused by the inhalation of the fungus P braziliensis. Animal-to-human and human-to-human transmissions do not appear to occur. Direct inoculation of the skin or mucosal surfaces is rare.
  • Rural workers, particularly woodcutters, are more frequently affected because of their increased contact with the soil.
  • Alcohol and possibly tobacco smoking is associated with disseminated disease.
  • South American blastomycosis has been identified as an AIDS-associated opportunistic infection. Patients with AIDS usually have a form of the disease that closely resembles the juvenile subacute type.[12]
  • Otherwise healthy patients who develop disseminated disease appear unable to mount a sufficient cellular immune response to the organism.
Previous
 
 
Contributor Information and Disclosures
Author

Julie E Dixon, MD, FAAD  Private Practice, Ironwood Dermatology, Tucson, Arizona

Julie E Dixon, MD, FAAD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Norman Levine  MD, Private practice, Tucson, AZ

Norman Levine is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Specialty Editor Board

Franklin Flowers, MD  Chief, Division of Dermatology, Professor, Department of Medicine and Otolaryngology, Affiliate Associate Professor of Pediatrics and Pathology, University of Florida College of Medicine

Franklin Flowers, MD, is a member of the following medical societies: American College of Mohs Micrographic Surgery and Cutaneous Oncology

Disclosure: Nothing to disclose.

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Jeffrey J Miller, MD  Associate Professor of Dermatology, Pennsylvania State University College of Medicine; Staff Dermatologist, Pennsylvania State Milton S Hershey Medical Center

Jeffrey J Miller, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Professors of Dermatology, North American Hair Research Society, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References
  1. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. Dec 2005;53(6):931-51, quiz 952-4. [Medline].

  2. Benard G, Kavakama J, Mendes-Giannini MJ, Kono A, Duarte AJ, Shikanai-Yasuda MA. Contribution to the natural history of paracoccidioidomycosis: identification of the primary pulmonary infection in the severe acute form of the disease--a case report. Clin Infect Dis. Jan 1 2005;40(1):e1-4. [Medline].

  3. Mayr A, Kirchmair M, Rainer J, Rossi R, et al. Chronic paracoccidioidomycosis in a female patient in Austria. Eur J Clin Microbiol Infect Dis. Dec 2004;23(12):916-9. [Medline].

  4. Maluf ML, Pereira SR, Takahachi G, Svidzinski TI. [Prevalence of paracoccidioidomycosis infection determined by sorologic test in donors' blood in the Northwest of Parana, Brazil]. Rev Soc Bras Med Trop. Jan-Feb 2003;36(1):11-6. [Medline].

  5. Cabral-Marques O, Schimke LF, Pereira PV, Falcai A, de Oliveira JB, Hackett MJ, et al. Expanding the Clinical and Genetic Spectrum of Human CD40L Deficiency: The Occurrence of Paracoccidioidomycosis and Other Unusual Infections in Brazilian Patients. J Clin Immunol. Dec 23 2011;[Medline].

  6. Nogueira LM, Santos M, Ferreira LC, Talhari C, Rodrigues RR, Talhari S. AIDS-associated paracoccidioidomycosis in a patient with a CD4+ T-cell count of 4 cells/mm³. An Bras Dermatol. Jul-Aug 2011;86(4 Suppl 1):S129-32. [Medline].

  7. Desjardins CA, Champion MD, Holder JW, Muszewska A, Goldberg J, Bailão AM, et al. Comparative genomic analysis of human fungal pathogens causing paracoccidioidomycosis. PLoS Genet. Oct 2011;7(10):e1002345. [Medline]. [Full Text].

  8. Blotta MH, Mamoni RL, Oliveira SJ, et al. Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am J Trop Med Hyg. Sep 1999;61(3):390-4. [Medline].

  9. Pereira RM, Tresoldi AT, da Silva MT, Bucaretchi F. Fatal disseminated paracoccidioidomycosis in a two-year-old child. Rev Inst Med Trop Sao Paulo. Jan-Feb 2004;46(1):37-9. [Medline].

  10. Sant'Anna GD, Mauri M, Arrarte JL, Camargo H Jr. Laryngeal manifestations of paracoccidioidomycosis (South American blastomycosis). Arch Otolaryngol Head Neck Surg. Dec 1999;125(12):1375-8. [Medline].

  11. de Almeida SM, Queiroz-Telles F, Teive HA, Ribeiro CE, Werneck LC. Central nervous system paracoccidioidomycosis: clinical features and laboratorial findings. J Infect. Feb 2004;48(2):193-8. [Medline].

  12. Corti M, Villafane MF, Negroni R, Palmieri O. Disseminated paracoccidioidomycosis with peripleuritis in an AIDS patient. Rev Inst Med Trop Sao Paulo. Jan-Feb 2004;46(1):47-50. [Medline].

  13. Marques da Silva SH, Queiroz-Telles F, Colombo AL, Blotta MH, Lopes JD, Pires De Camargo Z. Monitoring gp43 antigenemia in Paracoccidioidomycosis patients during therapy. J Clin Microbiol. Jun 2004;42(6):2419-24. [Medline].

  14. Yasuda MA. Pharmacological management of paracoccidioidomycosis. Expert Opin Pharmacother. Mar 2005;6(3):385-97. [Medline].

  15. da Silva SH, Grosso Dde M, Lopes JD, et al. Detection of Paracoccidioides brasiliensis gp70 circulating antigen and follow-up of patients undergoing antimycotic therapy. J Clin Microbiol. Oct 2004;42(10):4480-6. [Medline].

  16. Hay RJ. Antifungal drugs used for systemic mycoses. Dermatol Clin. Jul 2003;21(3):577-87. [Medline].

  17. Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM, Espinel-Ingroff A, Shikanai-Yasuda MA. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Clin Infect Dis. Dec 1 2007;45(11):1462-9. [Medline].

  18. Travassos LR, Taborda CP, Colombo AL. Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti Infect Ther. Apr 2008;6(2):251-62. [Medline].

  19. Ollague JM, de Zurita AM, Calero G. Paracoccidioidomycosis (South American blastomycosis) successfully treated with terbinafine: first case report. Br J Dermatol. Jul 2000;143(1):188-91. [Medline].

  20. Crissey JT, Lang H, Parish LC. Manual of Medical Mycology. Cambridge, Mass: Blackwell Sciences; 1995:128-34.

  21. Elder D, Elenitsas E, Jawarsky C, et al, eds. Lever's Histopathology of the Skin. 10th ed. Philadelphia, Pa: Lippincott-Raven; 2008.

  22. Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens, and Practice. 2nd ed. New York, NY: Churchill Livingstone; 2006.

  23. Richardson MD, Warnock DW, eds. Fungal Infection: Diagnosis and Management. 3rd ed. London, England: Bailliere Tindallk; 2003.

  24. Stickland GT, ed. Hunter's Tropical Medicine and Emerging Infectious Diseases. 8th ed. Philadelphia, Pa: WB Saunders; 2000:559-61.

Previous
Next
 
Crusted plaques over the central part of the face in a man with South American blastomycosis. Courtesy of Rolando Vasquez, MD, Professor of Dermatology, Guatemala.
Ulcerated nodule on the tongue in a man with South American blastomycosis. Courtesy of Heidi Logemann, Professor of Mycology, Universidad de San Carlos, Guatemala.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.